A

Advanced Biomed Inc
NASDAQ:ADVB

Watchlist Manager
Advanced Biomed Inc
NASDAQ:ADVB
Watchlist
Price: 0.35 USD 3.98% Market Closed
Market Cap: 7.6m USD

Advanced Biomed Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Advanced Biomed Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
A
Advanced Biomed Inc
NASDAQ:ADVB
EPS (Diluted)
$0
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
EPS (Diluted)
$8
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
6%
Laboratory Corporation of America Holdings
NYSE:LH
EPS (Diluted)
$10
CAGR 3-Years
-19%
CAGR 5-Years
3%
CAGR 10-Years
9%
CareDx Inc
NASDAQ:CDNA
EPS (Diluted)
$1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veracyte Inc
NASDAQ:VCYT
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neogenomics Inc
NASDAQ:NEO
EPS (Diluted)
$0
CAGR 3-Years
12%
CAGR 5-Years
-97%
CAGR 10-Years
N/A
No Stocks Found

Advanced Biomed Inc
Glance View

Market Cap
7.6m USD
Industry
N/A

Advanced Biomed Inc is a US-based company operating in industry. The company is headquartered in Reno, Nevada and currently employs 40 full-time employees. The company went IPO on 2025-03-06. Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

ADVB Intrinsic Value
0.13 USD
Overvaluation 62%
Intrinsic Value
Price
A

See Also

What is Advanced Biomed Inc's EPS (Diluted)?
EPS (Diluted)
-0.2 USD

Based on the financial report for Jun 30, 2025, Advanced Biomed Inc's EPS (Diluted) amounts to -0.2 USD.

What is Advanced Biomed Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
6%

Over the last year, the EPS (Diluted) growth was -23%. The average annual EPS (Diluted) growth rates for Advanced Biomed Inc have been 6% over the past three years .

Back to Top